Assessment of Barriers and Facilitators to Prescribing HIV Preexposure Prophylaxis by Primary Care Providers

Author:

Kilboy Matthew,Shihabuddin Courtney,Morgan Ethan,Herbell Kayla

Abstract

Abstract HIV preexposure prophylaxis (PrEP) is a highly effective class of drugs used to prevent the transmission of HIV-1. Despite its high efficacy, the uptake of PrEP has been very low. This project sought to understand the barriers and facilitators to prescribing PrEP in a community health clinic in a Midwestern state.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,Dermatology

Reference11 articles.

1. Preexposure prophylaxis for the prevention of HIV infection: Evidence report and systematic review for the US Preventive Services Task Force;JAMA,2019

2. Physician assistant's knowledge and confidence regarding prescribing preexposure prophylaxis for HIV prevention;Sex Transm Dis,2020

3. Perceived versus calculated HIV risk: Implications for pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men;J Acquir Immune Defic Syndr,2019

4. Are we prescribing enough HIV pre-exposure prophylaxis in Missouri?: A cross-sectional study at University of Missouri health care;Mo Med,2020

5. Knowledge, attitudes, and PrEP prescribing practices of health care providers in Philadelphia, PA;J Prim Care Community Health,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3